The contribution of differentiated bone marrow stromal stem cell-loaded biomaterial to treatment in critical size defect model in rats;Biyomateryal üzerinde farklılaşmış kemik İliǧi stromal kök hücrelerinin kritik hacim defektli sıçan modelinde uygulanmasının tedavideki yeri

Kafkas Universitesi Veteriner Fakultesi Dergisi

Volumn 16, Issue 5, 2010, Pages 783-792

  Tuǧlu, Mehmet Ibrahim ^a   Özdal Kurt, Feyzan ^a   Koca, Hüseyin ^b   Sarac, Aydin ^b   Barut, Turgay ^a   Kazanç, Aycan ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Bone marrow stromal cell; Critical size defect; Healing; Hydroxyapatite gel; NOS; Tissue engineering

Indexed keywords

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78149457996     PISSN: 13006045     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lombardi LJ, Cleri DJ, Zambito RF: Osteomyelitis. In, Immunology and Infectious Diseases of the Mouth, Head, and Neck. St. Louis, MO: Mosby, 114-131, 1991.
2. Kaban LB, Glowacki J: Induced osteogenesis in the repair of experimental mandibular defects in rats. J Dent Res, 60 (7): 1356-1364, 1981.
3. Sweeney TM, Opperman LA, Persing JA: Repair of critical size defects using extracellular matrix protein gels. J Neurosurg, 83, 710-715, 1995.
4. Schmitz JP, Hollinger JO: The critical size defect as an experimental model for craniomandibular nonunions. Clin Orthop, 205, 299-308, 1986.
5. Hollinger JO, Kleinschmidt JC: The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg, 1 (1): 60-68, 1990.
6. Kaban LB, Glowacki J, Murray JE: Repair of experimental mandibular bony defects in rats. Surg Forum, 30, 519-521, 1979.
7. Reddi AH: Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop, 355S, S66-S72, 1998.
8. Vacanti CA, Kim W, Upton J, Vacanti MP, Mooney D, Schloo B, Vacanti JP: Tissue-engineered growth of bone and cartilage. Transplant Proc, 25 (1): 1019-1021, 1993.
9. Bab I, Gazit D, Muhlrad A, Shteyer A: Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology, 123, 345-352, 1988.
10. Bruder SP, Fink DJ, Caplan AI: Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem, 56, 283-294, 1994.
11. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE: Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone, 21, 225-235, 1997.
12. Wlodarski KH: Properties and origin of osteoblasts. Clin Orthop Rel Res, 252, 276-293, 1990.
13. Caplan AI: Mesenchymal stem cells. J Orthop Res, 9, 641650, 1991
14. Li IWS, Cheifetz S, McCulloch CAG, Sampath KT, Sodek J: Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific. J Cell Physiol, 169, 115-125, 1996.
15. Lian JB, Stein GS: The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGFb1) and hormones (vitamin D and glucocorticoids). J Oral Implant, 19, 95-105, 1993.
16. Shi S, Kirk M, Kahn AJ: The role of type I collagen in the regulation of the osteoblast phenotype. J Bone Min Res, 11, 1139-1145, 1996.
17. Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem, 64, 278-294, 1997.
18. Holmes RE, Bucholz RW, Mooney V: Porous hydroxyapatite as a bone graft substitute in diaphyseal defects: A histometric study. J Orthop Res, 5, 114-121, 1987.
19. Hollinger JO, Brekke J, Gruskin E, Lee D: Role of bone substitutes. Clin Orthop, 324, 55-65, 1996.
20. Johnson KD, Frierson KE, Keller TS, Cook C, Scheinberg R, Zerwekh J, Meyers L, Sciadini MF: Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis. J Orthop Res, 14, 351369, 1996.
21. Saito N, Okada T, Horiuchi H, Murakami N, Takahashi J, Nawata M, Ota H, Miyamoto S, Nozaki K, Takaoka K: Biodegradable poly-D, L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg Am, 83-A Suppl 1 (Pt 2): S92-S98, 2001.
22. Solchaga LA, Dennis JE, Goldberg VM, Caplan AI: Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J Orthop Res, 17 (2): 205-213, 1999.
23. Sayer M, Stratilatov AD, Reid J, Calderin L, Stott MJ, Yin X, MacKenzie M, Smith TJ, Hendry JA, Langstaff SD: Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials, 24 (3): 369-382, 2003.
24. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S: Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res, 16, 155-162, 1998.
25. Kadiyala S, Young RG, Thiede MA, Bruder SP: Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant, 6, 125-134, 1997.
26. Maniatopoulos C, Sodek J, Melcher A: Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res, 254, 317-330, 1988.
27. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG: Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res, 36, 17-28, 1997.
28. Deliloglu-Gürhan SI, Tuǧlu I, Vatansever HS, Özdal-Kurt F, Ekren H, Taylan M, Sen BH: The effect of osteogenic medium on the adhesion of rat bone marrow stromal cell (BMSC) to the hydroxyapatite (HA). Saudi Med J, 27 (3): 305311, 2006.
29. Deliloglu-Gürhan SI, Vatansever HS, Özdal-Kurt F, Tuǧlu I: Characterization analysis of osteoblast derived from bone marrow in modified culture system. Acta Histochem, 108, 4957, 2006.
30. Porter RM, Huckle WR, Goldstein AS: Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem, 90 (1): 13-22, 2003.
31. Liu P, Oyajobi BO, Russell RG, Scutt A: Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1, 25(OH)(2) vitamin D(3) in vitro. Calcif Tissue Int, 65 (2): 173-180, 1999.
32. Ripamonti U, Ma S, Cunningham NS, Yeates L, Reddi AH: Initiation of bone regeneration in adult baboons by osteogenin, a bone morphogenetic protein. Matrix, 12 (5): 369-380, 1992.
33. Langstaff S, Sayer M, Smith TJ, Pugh SM: Resorbable bioceramics based on stabilized calcium phosphates. Part II: Evaluation of biological response. Biomaterials, 22 (2): 135150, 2001.
34. Arosarena OA, Falk A, Malmgren L, Bookman L, Allen MJ, Schoonmaker J, Tatum S, Kellman R: Defect repair in the rat mandible with bone morphogenic proteins and marrow cells. Arch Facial Plast Surg, 5 (1): 103-108, 2003.
35. Topcu I, Vatansever S, Var A, Cavus Z, Cilaker S, Sakarya M: The effect of Misoprostol, a prostaglandin E1 analog, on apoptosis in ischemia-reperfusion-induced intestinal injury. Acta Histochem, 109 (4): 322-329, 2007.
36. Ergün G, Aktaş S: ANOVA modellerinde kareler toplami{dotless} yöntemlerinin karşi{dotless}laşti{dotless}ri{dotless}lmasi{dotless}. Kafkas Univ Vet Fak Derg, 15 (3): 481-484, 2009.
37. Dupoirieux L, Pourquier D, Picot MC, Neves M: Comparative studyof three different membranes for guided bone regeneration of rat cranial defects. Int J Oral Maxillofac Surg, 30, 58-62, 2002.
38. Beirne OR: Comparison of complication after bone removal from the lateral and medial plates of the ilium for mandibular augmentation. Int J Oral Surg, 15, 267-270, 1986.
39. Cancedda R, Mastrogiacomo M, Bianchi G, Derubeis A, Muraglia A, Quarto R: Bone marrow stromal cells and their use in regenerating bone. Novartis Foundation Symposium, 249, 133-143, 2003.
40. Yamamoto M, Tabata Y, Hong L, Miyamoto S, Hashimoto N, Ikada Y: Bone regeneration bytransformin g growth factor b1 released from a biodegradable hydrogel. J Control Rel, 64, 133-142, 2000.
41. Hong L, Tabata Y, Miyamoto S, Yamamoto M, Yamada K, Hashimoto N, Ikada Y: Bone regeneration at rabbit skull defects treated with transforming growth factor-b1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg, 92, 315-325, 2000.
42. Mastrogiacomo M, Corsi A, Francioso E, Di Comite M, Monetti F, Scaglione S, Favia A, Crovace A, Bianco P, Cancedda R: Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng, 12 (5): 12611273, 2006.
43. Koerten HK, van der Meulen J: Degradation of calcium phosphate ceramics. J Biomed Mater Res, 44 (1): 78-86, 1999.
44. Bell R, Beirne OR: Effect of hydroxyappatite, tricalcium phosphate, and collagen on healing of defects in the rat mandible. J Oral Maxillofac Surg, 46, 589-594, 1988.
45. Okumura M, Ohgushi H, Dohi Y, Katuda T, Tamai S, Koerten HK, Tabata S: Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res, 37 (1): 122-129, 1997.
46. Anada T, Kumagai T, Honda Y, Masuda T, Kamijo R, Kamakura S, Yoshihara N, Kuriyagawa T, Shimauchi H, Suzuki O: Dose-dependent osteogenic effect of octacalcium phosphate on mouse bone marrow stromal cells. Tissue Eng, Part A, 14 (6): 965-978, 2008.
47. Fialkov JA, HolyCE, Shoichet MS, Davies JE: In vivo bone engineering in rabbit femur. J Craniofac Surg, 14, 324-332, 2003.
48. Włodarski KH, Włodarski PK, Galus R: Bioactive composites for bone regeneration. Ortop Traumatol Rehabil, 10 (3): 201-210, 2008.
49. Tracy BM, Doremus RH: Direct electron microscopy study of the bone-hydroxyapatite interface. J Biomed Mater Res, 18, 719-726, 1994.
50. Arosarena OA, Collins WL: Defect repair in the rat mandible with bone morphogenetic protein 5 and prostaglandine E1. Arch Otolaryngol Head Neck Surg, 129, 1125-1130, 2003.
51. Kadiyala S, Jaiswal N, Bruder SP: Culture-ex-panded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Eng, 3, 173185, 1997.